Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.2058 USD | -19.89% |
|
-2.00% | -69.15% |
Business Summary
Number of employees: 21
Managers
Managers | Title | Age | Since |
---|---|---|---|
Ken Berlin
CEO | Chief Executive Officer | 59 | 18-03-31 |
Shmuel Tuvia
CTO | Chief Tech/Sci/R&D Officer | - | 22-04-30 |
General Counsel | - | 17-12-31 | |
Human Resources Officer | - | 18-12-31 | |
Dana Gelbaum
PRN | Corporate Officer/Principal | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
David Sidransky
CHM | Chairman | 64 | 17-10-31 |
Roni Appel
BRD | Director/Board Member | 57 | 04-10-31 |
Murray Goldberg
BRD | Director/Board Member | 79 | 17-11-30 |
Robert Spiegel
BRD | Director/Board Member | 73 | 17-11-30 |
Pini Orbach
BRD | Director/Board Member | - | 23-10-18 |
Ken Berlin
CEO | Chief Executive Officer | 59 | 18-03-31 |
Director/Board Member | 53 | 20-07-31 | |
Yuval Cabilly
BRD | Director/Board Member | 44 | 23-10-18 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 42,672,852 | 42,632,797 ( 99.91 %) | 39,452 ( 0.0925 %) | 99.91 % |
Company contact information
Ayala Pharmaceuticals, Inc.
9 Deer Park Drive Suite K-1
08852, Monmouth Junction
+
http://www.ayalapharma.com![address Ayala Pharmaceuticals, Inc.(ADXS)](https://cdn.zonebourse.com/static/address/56593690.png)
Sector
![Consensus](/images/consensus_flch.gif)
Chiffre d''affaires - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-69.15% | 10.15M | |
+17.72% | 44.87B | |
-10.33% | 37.8B | |
+40.60% | 37.61B | |
+29.36% | 31.32B | |
-8.44% | 27.4B | |
+12.45% | 26.32B | |
+44.19% | 14.07B | |
+31.93% | 12.5B | |
-7.67% | 11.23B |
- Stock Market
- Equities
- ADXS Stock
- Company Ayala Pharmaceuticals, Inc.